PIPS Key Facts
| Active Substance |
- NETUPITANT
- PALONOSETRON HYDROCHLORIDE
|
Invented Name
|
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
- AKYNZEO
|
| PIP Number |
MHRA-102387-PIP01-26 |
|
Pharmaceutical form(s)
|
Pharmaceutical form(s):
|
|
Therapeutic area
|
Therapeutic area:
- Other: Cancer supportive care
|
|
Conditions / Indications
|
Conditions / Indications:
- Prevention of chemotherapy-induced nausea and vomiting
|
|
Route(s) of administration
|
Route(s) of administration:
|
|
PIP applicant
|
|
|
Decision Type
|
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
|
|
Compliance Check
|
|
|
Compliance Check Decision Date
|
|
|
Compliance Check Procedure Number
|
|
